In a report released today, Tavy Rosner from Barclays maintained a Buy rating on Amdocs (DOX – Research Report), with a price target of $111.00. The company’s shares closed yesterday at $87.75.

In a report released today, Timothy Horan from Oppenheimer maintained a Buy rating on Amdocs (DOX – Research Report), with a price target of $105.00. The company’s shares closed yesterday at ...

Amdocs (DOX) came out with quarterly earnings of $1.70 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.42 per share a year ago. These figures are adjusted for ...

COPENHAGEN, Denmark, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the third quarter ended September 30, 2024, and provided a business ...

Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, TransCon, SKYTROFA®, and YORVIPATH® are trademarks owned by the Ascendis Pharma group.

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

CHICAGO, Nov. 11, 2024 /PRNewswire/ -- ResQ Pharma, Inc., a Chicago-based pharmaceutical company developing and commercializing innovative drug therapies, today announced that it has received a ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser. Combing through ...

NEW YORK, Oct 31 (Reuters) - Purdue Pharma is close to a new bankruptcy settlement with its owners, members of the wealthy Sackler family, and state and local governments that have filed lawsuits ...

A rumor that food company Land O'Lakes had announced a return to its previous logo featuring a kneeling Indigenous woman on its packaging circulated online in October 2024. A Facebook post ...

Tension flared up in a village in Telangana's Vikarabad district on Monday after some villagers protesting the acquisition of their lands for a proposed 'pharma village' allegedly attacked the ...